相关实验视频

Updated: Jan 18, 2026

Author Spotlight: Utilizing Venoplasty Balloon Model in Rodents to Simulate Surgical Interventions for Deep Veins

Author Spotlight: Utilizing Venoplasty Balloon Model in Rodents to Simulate Surgical Interventions for Deep Veins

Published on: May 24, 2024

深静脉血栓症的潜在治疗点:一个全蛋白质组的门德尔随机化研究

JiaHao Liu¹, YuanZhuo Du¹, XiaoQiang Liu¹

¹The First Affiliated Hospital of Nanchang University, Nanchang, China.

|June 4, 2025

概括

这项研究确定了12种与深静脉血栓形成 (DVT) 有因果关系的血蛋白. 一些蛋白质增加了DVT的风险,而另一些蛋白质则提供了保护,为DVT治疗提出了新的治疗点.

科学领域:

遗传学遗传学是一种遗传学.
蛋白质组学是指蛋白质组学.
心血管医学心血管医学

背景情况:

下肢深静脉血栓 (DVT) 构成严重的健康风险.
对于有效的DVT治疗,急需新的药物标.

研究的目的:

通过全蛋白质门德尔随机化方法,研究血蛋白和DVT之间的因果关系.
为了确定潜在的治疗目标和生物标志物用于DVT查和管理.

主要方法:

整个蛋白质组的孟德尔随机化 (MR) 研究利用了来自35,559名参与者的数据.
采用多种分析方法,复制分析,调解MR和路径丰富分析.
进行了药物适用性评估和全现象MR分析,以评估药物开发.

主要成果:

确定了12种与DVT有显著因果关联的血蛋白.
MAP1LC3A,LRP12,VWF,F2,SYK,F11,KLKB1和LRP4显示DVT风险增加;SERPINE2,XXYLT1,PMVK和RGS18显示具有保护作用.
LRP12和F11提供了最有力的证据;确定了F2-Triglycerides-DVT和MAP1LC3A-eGFR-DVT通路;几个蛋白质 (F11,F2,KLKB1,SYK,VWF) 已经是药物点.

结论:

确定了12个与下肢DVT相关的新型蛋白质标.
这些发现为开发新的DVT治疗剂和生物标志物提供了有希望的途径.
该研究强调了LRP12,F11,F2,KLKB1,SYK和VWF在DVT药物开发和查中的潜力.

关键词:

这是一个DVT,DVT.门德尔的随机化生物标志物生物标志物毒品目标是毒品的目标.血蛋白质组中的血蛋白质组

更多相关视频

Mouse Complete Stasis Model of Inferior Vena Cava Thrombosis

Mouse Complete Stasis Model of Inferior Vena Cava Thrombosis

Published on: June 15, 2011

Deep Vein Thrombosis Induced by Stasis in Mice Monitored by High Frequency Ultrasonography

Deep Vein Thrombosis Induced by Stasis in Mice Monitored by High Frequency Ultrasonography

Published on: April 13, 2018

相关概念视频

Venous Thrombosis III: Interprofessional Care

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

Venous Thrombosis I: Introduction

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...